Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register

Eitemau Tebyg

• No Evidence of Association Between Anti–Tumor Necrosis Factor Treatment and Mortality in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register
  gan: Lunt, Mark, et al.
  Cyhoeddwyd: (2010)
• Rituximab or a second anti–tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti–tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register
  gan: Soliman, Moetaza M, et al.
  Cyhoeddwyd: (2012)
• Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register
  gan: Dixon, W G, et al.
  Cyhoeddwyd: (2010)
• The British Society for Rheumatology Biologics Register
  gan: Watson, K, et al.
  Cyhoeddwyd: (2005)
• Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
  gan: Mercer, Louise K, et al.
  Cyhoeddwyd: (2015)